Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).

Neuroscience letters - 29 Oct 2007

Déniz-Naranjo Maria Cándida, Muñoz-Fernández Carmen, Alemany-Rodríguez Maria Jesús, del Carmen Pérez-Vieitez Maria, Aladro-Benito Yolanda, Irurita-Latasa Juncal, Sánchez-García Florentino

Abstract excerpt

AIM: Cholinergic dysfunction is a major neurochemical feature in Alzheimer's disease (AD), accountable for many cognitive dysfunctions and some psychiatric symptoms. Butyrylcholinesterase (BChE) is one of the cholinesterases with increased activity in the brain of Alzheimer's patients. Several mutations code for different BChE, such as the K variant, which is the most common and is capable of reducing BChE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylcholine
Share to Age of Onset

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Apolipoproteins E

Share to Brain Chemistry

Share to Butyrylcholinesterase

Share to Racial Groups

Source

Identifiers

PMID: 17923322
DOI: 10.1016/j.neulet.2007.08.059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).PMID 17923322Read ↗

Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.Semantic proximity Read ↗

Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?Semantic proximity Read ↗

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.Semantic proximity Read ↗

Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.Semantic proximity Read ↗

Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.Semantic proximity Read ↗

BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.Semantic proximity Read ↗

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.Semantic proximity Read ↗

Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.Semantic proximity Read ↗

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.Semantic proximity Read ↗

Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.Semantic proximity Read ↗

Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.Semantic proximity Read ↗

Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer's Disease: An Observational Case-Control Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.